NCT02053974View on ClinicalTrials.gov

Spironolactone Against Anthracycline-induced Cardiomyopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Anthracycline Induced Cardiotoxicity
Interventions
DRUG

Spironolactone

Spironolactone

OTHER

Placebo

Placebo

Trial Locations (1)

38039

Erciyes University School of Medicine, Kayseri

All Listed Sponsors
lead

TC Erciyes University

OTHER

NCT02053974 - Spironolactone Against Anthracycline-induced Cardiomyopathy | Biotech Hunter | Biotech Hunter